In addition to the inhibition of inflammatory- and fibrotic-mediated signaling pathways, which could account for the protective effects of CNP and CNA, a drug with antioxidative potential, such as resveratrol, can improve urinary dysfunction in rats with chronic prostatitis and suppress the SCF/c-Kit signaling pathway activity [42]. This evidence concerns the gene KITLG and prostatitis.